Efficacy of Non-invasive Neuromodulation Treatments for COVID-19 Sequelae

NANot yet recruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

December 1, 2026

Study Completion Date

December 30, 2026

Conditions
Covid-19 Recurrent
Interventions
DEVICE

Non invasive neuromodulation therapy

"In the 4 studies, the intervention consisted of 15 sessions spread over 5 weeks.~Each intervention lasted 60 minutes. The intensity will be programmed in all sessions at Low, following the Arndt-Schulz law. The treatment was distributed in 3 phases: phase 1 of preparation, phase 2 to reduce fatigue and phase 3 to enhance autonomic improvement."

OTHER

Manual therapy

Common manual therapy administered for said pathology by traditional physiotherapy and therapeutic exercise.

DEVICE

Placebo with non invasive neuromodulation

"In the 4 studies, the intervention consisted of 15 sessions spread over 5 weeks.~Each intervention lasted 60 minutes. The treatment was carried out with the machine turned off."

Trial Locations (1)

14011

Gema León Physiotherapy and Rehabilitation Clinic, Córdoba

All Listed Sponsors
lead

Clinica Gema Leon

OTHER

NCT06544395 - Efficacy of Non-invasive Neuromodulation Treatments for COVID-19 Sequelae | Biotech Hunter | Biotech Hunter